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Neuronal plasticity peaks during critical periods of postnatal development and is reduced
towards adulthood. Recent data suggests that windows of juvenile-like plasticity can
be triggered in the adult brain by antidepressant drugs such as Fluoxetine. Although
the exact mechanisms of how Fluoxetine promotes such plasticity remains unknown,
several studies indicate that inhibitory circuits play an important role. The polysialylated
form of the neural cell adhesion molecules (PSA-NCAM) has been suggested to mediate
the effects of Fluoxetine and it is expressed in the adult brain by mature interneurons.
Moreover, the enzymatic removal of PSA by neuroaminidase-N not only affects the
structure of interneurons but also has been shown to play a role in the onset of critical
periods during development. We have here used ocular dominance plasticity in the
mouse visual cortex as a model to investigate whether removal of PSA might influence
the Fluoxetine-induced plasticity. We demonstrate that PSA removal in the adult visual
cortex alters neither the baseline ocular dominance, nor the fluoxetine-induced shift
in the ocular dominance. We also show that both chronic Fluoxetine treatment and
PSA removal independently increase the basal FosB expression in parvalbumin (PV)
interneurons in the primary visual cortex. Therefore, our data suggest that although
PSA-NCAM regulates inhibitory circuitry, it is not required for the reactivation of juvenile-
like plasticity triggered by Fluoxetine.
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INTRODUCTION
Critical periods during development have been characterized as time-windows of high plasticity
during which the external milieu shapes networks and behavior (Katz and Shatz, 1996; Berardi et al.,
2000). In the visual cortex, the classical studies of Hubel andWiesel showed how ocular dominance
columns are established during a critical period in postnatal development of the visual system
in cats (Wiesel and Hubel, 1963). After that time-window of enhanced plasticity, the established
ocular dominance will remain permanent (Hubel and Wiesel, 1970). Disturbance of normal
binocular vision during such critical period, in animal models usually by monocular deprivation,
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leads to disrupted integration of visual information in the cortex.
The altered balance of information arriving to the visual cortex
from the occluded eye results in reduced visual acuity and
contrast sensitivity (Dews andWiesel, 1970; Fagiolini et al., 1994;
Prusky et al., 2000), a condition known in humans as amblyopia
(Webber and Wood, 2005).
Although the visual system of rodents lacks characteristic
columns described in higher mammals, critical periods for ocular
dominance have nevertheless been extensively characterized in
rodents as well (Kirkwood and Bear, 1994; Kirkwood et al., 1995;
Huang et al., 1999). Interestingly, recent reports have shown
that a critical period-like plasticity can be reopened in the adult
visual cortex through different experimental manipulations (Sale
et al., 2009; Bavelier et al., 2010; Beurdeley et al., 2012) including
antidepressant drugs such as Fluoxetine (Maya-Vetencourt et al.,
2008; Tiraboschi et al., 2013). The combination of Fluoxetine
with monocular deprivation of one eye in adult rats produces a
shift in the ocular dominance towards the open eye. This shift
resembles that achieved by the same paradigm of monocular
deprivation during the developmental critical period (Maya-
Vetencourt et al., 2008).
Cellular andmolecular mechanisms that have been connected
with the Fluoxetine-induced opening of critical periods in
adult brain include rearrangement of inhibitory circuits (Maya-
Vetencourt et al., 2008), signaling by Brain-derived neurotrophic
factor (BDNF; Maya-Vetencourt et al., 2008), serotoninergic
transmission (Maya-Vetencourt et al., 2010; Ferrés-Coy et al.,
2015) and the transcription factor NPAS4 (Maya-Vetencourt
et al., 2012), but detailed molecular mechanisms through
which Fluoxetine reopens critical periods are still unclear
(Maya-Vetencourt et al., 2012; Sharp, 2013; Tiraboschi et al.,
2013). A promising candidate to mediate this mechanism
is the polysialylated form of neural cell adhesion molecules
(PSA-NCAM), a molecule widely expressed during development
but subsequently restricted, in the adult neocortex, to a
subpopulation of interneurons (Sandi, 2004; Rutishauser, 2008).
PSA-NCAM is a negatively charged hydrophilic molecule that
creates a steric impediment affecting membrane receptors
and signaling (Burgess and Aubert, 2006; Gascon et al.,
2007). NCAM is the major polysialylated molecule in the
adult brain and its polysialylation has been linked with
adult brain plasticity (Bonfanti, 2006; Nacher et al., 2013).
Particularly, chronic antidepressant treatments have been
reported to increase PSA-NCAM expression in different
brain regions (Sairanen et al., 2007; Varea et al., 2007;
Guirado et al., 2014b). Conversely, enzymatic removal of
PSA has been shown to disrupt plastic mechanisms such
as LTP (Muller et al., 1996; Dityatev et al., 2004); effects
that can be counteracted by BDNF supplementation (Muller
et al., 2000). In addition, PSA removal has also been
suggested to trigger an earlier onset of critical periods
in the visual cortex through the precocious maturation
of the perisomatic innervation of pyramidal neurons by
basket cells and enhancing inhibitory synaptic transmission
(Di Cristo et al., 2007). In fact, PSA depletion during
adulthood also induces an increase in this perisomatic inhibitory
input (Castillo-Gómez et al., 2011). All these studies suggest
that regulation of PSA-NCAM expression is a possible
mechanism mediating the effects of Fluoxetine in the adult brain
plasticity.
To investigate the interaction between PSA-NCAM and
Fluoxetine, we studied the effects of enzymatic removal of
the polysialic acid moiety of PSA-NCAM on a critical period
plasticity paradigm: the shifts of ocular dominance in the visual
cortex during Fluoxetine chronic treatment.
MATERIALS AND METHODS
Animals
Forty-eight C57BL/6 female mice (Harlan Laboratories,
Netherlands) were used. Animals were divided into 4 different
groups of 12 to control two experimental manipulations:
Fluoxetine treatment and Endoneuraminidase-N (endoN)
intracerebral injections (group 1: no manipulation; group 2:
Fluoxetine only; group 3: EndoN only; group 4: Fluoxetine
and EndoN). The animals were caged in groups of four and
kept under standard housing conditions (21◦C, 12 h light/12 h
dark cycle, lights on at 6 AM). Mice were 3 months old at
the beginning of the experiment, ensuring that the shift in the
ocular dominance took place after P110 when the extended
critical period has been suggested to end (Greifzu et al., 2014).
All animals had free access to food and water for the entire
duration of the experimentation. All procedures were carried
out according to the Directive 2010/63/EU of the European
Parliament and were approved by the Animal Ethical Committee
of Southern Finland.
Visual Abilities
Following a previously described methodology (Drapeau et al.,
2014), general visual acuity was tested by using the visual
placing test, which takes advantage of the forepaw-reaching
reflex: the mouse was held by its tail approximately 20 cm
above the surface and was then progressively lowered. As it
approaches the surface, the mouse should expand its forepaws
to reach the floor. The test was repeated three times with
a 30 s interval, and the distance from the ground when the
animals show the forepaw reflex without using their whiskers was
quantified.
Fluoxetine Treatment
Mice received Fluoxetine via drinking water. Drinking water
was supplemented with 0.16 mg/mL Fluoxetine and 0.5%
sucrose. Solutions were prepared fresh twice a week, and
drinking bottles protected from light. We started the treatment
immediately after the cranial window surgery, and it lasted
for 4 weeks until the end of the experiment (Figure 1). The
level of Fluoxetine/water consumed and animal bodyweight
were constantly monitored to evaluate drug dose, which
was approximately 20 mg/Kg/day. This protocol of chronic
Fluoxetine administration to adult mice was reported to result
in clinical relevant plasma levels of the drug (Dulawa et al.,
2004).
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FIGURE 1 | Experimental design. Schematic graph showing the different
animal groups (G1 to G4) and the different experimental conditions conducted
at different time-points.
Chronic Cranial Window Surgical
Procedure
Three weeks prior to the first imaging session animals were
implanted flush with cranial windows in their right hemisphere,
following a protocol adapted from Holtmaat et al. (2009). In
short: anesthesia was induced with 3–4% Isoflurane (Vetflurane),
then continued with intraperitoneal (IP) injection of sleeping
cocktail: Fentanyl (opioid receptor agonist; 0.05 mg/kg),
Midazolam (GABA-A agonist; 5.0 mg/Kg) and Medetomidine
(adrenergic receptor agonist; 0.5 mg/Kg). Animals were placed
in a stereotaxic frame, the skin and periosteum were removed
and the right temporalis muscles separated from the bone.
With this procedure a large area of the skull was exposed.
Using a small amount of cyanoacrylate (Vetbond) we seal
the skin on the sides. A circular groove was drawn using
a surgical drill. Then, the bone piece was lifted leaving the
dura intact. A 5 mm diameter circular cover glass (EMS) was
flushed on. Glue gel (Loctite) was applied around the borders
and under a metal head bar to glue it to the skull. Finally,
dentist cement was applied around the craniotomy to cover all
tissues exposed, except a small area ipsilateral to the cranial
window, covered with putty for the following intracerebral
injection.
Stereotaxic Injection of EndoN
As previously described, mice were anesthetized first with
isoflurane and then with a sleeping cocktail. Additionally,
animals were injected subcutaneously with carprofen (Rimadyl;
5 mg/Kg) and intramuscularly with dexamethasone (0.6 mg/Kg),
for pre-emptive analgesia and anti-inflammatory effects.
Then placed in a stereotaxic frame, the piece of putty was
removed for the intracerebral injection. The enzyme endoN
(0.7 U/µL in glycerol; AbCys) or the vehicle solution (1 µl;
saline and glycerol 1:1) was injected using a Hamilton
syringe in the ipsilateral hemisphere to the cranial window
within the somatosensory cortex (antero-posterior −0.5 mm,
medio-lateral −1.5 mm, dorso-ventral −0.7 mm, relative
to Bregma). The needle was left in position for 1 min
and then 1 µL of endoN or vehicle was injected during
another minute. After the injection was completed, the
needle was left in place for 3 min to reduce reflux of the
solution into the track of the injection needle and then slowly
withdrawn.
After all surgical procedures, animals received an IP
injection with a wake-up cocktail containing antagonists
of the same receptors affected by the sleeping cocktail:
Naloxone (1.2 mg/Kg), Flumazenil (0.5 mg/Kg) and Atipamezole
(2.5 mg/Kg).
In Vivo Imaging of Intrinsic Signals
We adapted ourmethodology from a previous protocol described
by the laboratory of Dr Stryker (Kalatsky and Stryker, 2003;
Cang et al., 2005) to measure saturation of hemeoglobin as an
indicator of cortical activity in the mouse visual cortex. Mice
were injected IP with a lower dose (2/3 of the surgical dose)
of the sleeping cocktail to produce a shallow anesthesia. Then,
animals were placed in the setup, under a high frequency CCD
camera (Brain Imager 3001/S) 25 cm in front of a screen. The
cranial window was illuminated with red light using a broad
pass filter (630 ± 20 nm), and the camera focused 500 µm
below the surface area with a field of view roughly matching
the full extent of the cranial window. We produced a visual
stimulus consisting in a two degrees-thick horizontal bar in a
position between −15 and +5 degrees azimuth (relative to the
field of vision of the animal). The bar flickered at 6 Hz and
drifted vertically with cycles corresponding to 0.11 Hz to elicit
rhythmic activity at the same frequency in the right hemisphere
from both ipsilateral and contralateral eyes. Four stimulation
protocols were performed: two for each eye, and within one
eye one moving upwards and one downwards. In each protocol,
images of dimensions 336× 336 pixels were sampled at 10 Hz for
5 min.
Monocular Deprivation
After the first imaging session animals still under light anesthesia
were implanted with eye occluders in the left eye (contralateral to
the cranial window). These occluders were made as previously
described (Park et al., 2005). In short, they were made from
0.25 mm thick black vinyl sheets that were heated and molded
over a steel ball similar in size to the mice eyes. Mice from all
groups were subjected to monocular deprivation during 7 days,
after which they underwent a second imaging session. In a
separate pilot experiment we ensured that there are no responses
in the visual cortex when the animals wearing occluders are
exposed to the same visual stimulus.
Analysis of Imaging Data
Images were analyzed offline with custom-made scripts in
matlab (MATLAB 7.8, The MathWorks, Inc). These scripts
are freely available upon request. Images were stacked in the
time-domain and Fourier-transformed in that dimension to
extract a map of signal amplitude and phase at 0.11 Hz (the
stimulation frequency). Amplitude images for stimuli moving
upwards and downwards were averaged together, leaving us
with one amplitude image per eye (contralateral and ipsilateral).
Images were further smoothed with a 10-pixels-wide full-width-
at-half-maximum Gaussian kernel in order to decrease the
noise level. A region of interest that in principle matches with
the location of the primary visual cortex was then defined
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as the pixels for which the image for the contralateral eye
take values above 70% of the maximum of that same image.
Finally, the ocular dominance index (ODI) was defined as
ODI = (Acontra − Aipsi)/(Acontra + Aipsi), where Acontra (and
Aipsi respectively) is the mean amplitude of the image for
the contralateral (resp. ipsilateral) eye within the region of
interest. Phase maps masked outside the region of interest were
used to confirm that cortical activity is entrained according
to the known retinotopy; i.e., with a phase in each cortical
areas directly related to its most responsive polar angle. Mice
who failed to demonstrate systematic activity at 0.11 Hz and
expected retinotopy were excluded from further analysis of
the ODI.
Perfusion
One day after the second in vivo imaging session, animals were
perfused transcardially under deep pentobarbital anesthesia,
first with saline and then with PFA 4% in PB 0.1 M. After
perfusions, brains were extracted and postfixed in the same
fixative solution for 2 h, then stored in PB 0.1 M with sodium
azide 0.05%. Then brains were cut into 50 µm sections using
a vibratome (VT 1000E, Leica). Sections were collected in six
different subseries and stored at 4◦C in PB 0.1 M and sodium
azide.
Immunohistochemistry
Tissue was processed free-floating for fluorescence
immunohistochemistry as follows. Sections were washed in
PBS, then slices were incubated in 10% normal donkey serum
(NDS; Gibco), 0.2% Triton-X100 (Sigma) in PBS for 1 h.
Sections were then incubated for 48 h at 4◦C with IgM mouse
anti-PSA-NCAM (1:500; DSHB) or with a cocktail containing
IgG mouse anti-parvalbumin (1:2000; Swant) and IgG rabbit
anti-FosB (1:500; Santa Cruz) antibodies diluted in PBS 0.2%
Triton-X100. After washing again, sections were incubated for
2 h at room temperature with secondary antibody anti-mouse
IgM conjugated with A488 (1:200; Life Technologies) or with
a cocktail containing: anti-mouse IgG conjugated with Alexa
647 and anti-rabbit IgG conjugated with Alexa 488 (1:200; Life
Technologies). Sections were then washed in PB 0.1 M, mounted
on slides and coverslipped using fluorescence mounting medium
(Dako).
Confocal Imaging
Sections were analyzed using a confocal microscope (Zeiss
LSM 700). We evaluated PSA-NCAM expression and quantified
PV and FosB fluorescence intensity in two different sections
containing primary visual cortex (between +3 and +3.7mm in the
Antero-Posterior relative to Bregma). Stacks were obtained at an
optimal penetration depth in the tissue (1–6 µm deep). We used
same acquiring conditions (as any other previous condition) to
compare then the intensity of fluorescence between the samples.
For PSA-NCAM quantification, small square areas of 500 µm2
were analyzed in deep layers of two different sections within
the primary visual cortex of each animal. For FosB and PV
quantification, all PV neurons were counted in that same optimal
penetration depth in the tissue, then the nucleus stained with
FosB was profiled and its fluorescence intensity quantified for
both channels: FosB and PV. A total of 639 PV neurons were
analyzed, although for statistical purposes we always used the
number of animals as ‘‘n’’. All animals were coded and the code
was not broken until the end of the study.
RESULTS
EndoN Efficiently Depletes PSA-NCAM in
the Visual Cortex
We analyzed the expression of the PSA-NCAM in the primary
visual cortex of all the animals (Figure 2A). Intracerebral
injections of the enzyme endoN produced a clear depletion of
PSA-NCAM. Two weeks after the injection of the enzyme, the
depletion covered most parts of the telencephalon, including
always the visual cortex of the right hemisphere where the cranial
windows were placed (Figure 2B). In these areas the enzyme
effectively removed PSA-NCAM (2-way ANOVA; endoN effect:
F(1,24) = 17.02 and p = 0.0004; Figure 2C). In addition, Fluoxetine
treatment increased the expression of PSA-NCAM (Fisher’s LSD;
p = 0.0004) in control animals as previously described (Varea
et al., 2007).
Fluoxetine Produces a Shift in the Ocular
Dominance but EndoN Does Not
Before the start of the experiment, all animals were evaluated
for gross visual acuity. Three animals failed to show the forepaw
reflex without using their whiskers and were removed from the
study. The rest of the animals, showing at least one successful
forepaw reflex without using the whiskers, were therefore used
for the paradigm of visual plasticity (Figure 3B).
We then analyzed the effects of Fluoxetine and endoN
in a paradigm of visual plasticity. By measuring the activity
during visual stimulation in each eye, we calculated values
of ODI as previously described (Cang et al., 2005) for each
animal before and after monocular deprivation (Figure 3A).
Briefly, we calculated the shift in ODI for each animal that
occurred between the first imaging session (before monocular
deprivation) and the second imaging session (after monocular
deprivation). Of the 45 animals analyzed, 14 failed to reveal
systematic activity at stimulation frequency (0.11 Hz) and were
therefore not included in further analyses, leaving us with
31 animals (no manipulation: 8; Fluoxetine only: 6; EndoN
only: 8; Fluoxetine and EndoN: 9). We found that animals
not treated with Fluoxetine did not undergo any shift in ODI,
regardless of whether they were intracerebrally injected with
endoN (paired t-test before vs. after MD; p = 0.29), or with
vehicle (paired t-test; p = 0.49), indicating that PSA removal
did not influence basal visual responses. Fluoxetine treatment
induced a significant shift of the ODI towards the non-occluded
eye in the control (vehicle-injected) mice, consistent with
previous findings in rats (Maya-Vetencourt et al., 2008; paired
t-test; p = 0.035, Figure 3C). Similarly, Fluoxetine also produced
a similar significant shift in the ODI in mice intracerebrally
injected with endoN (paired t-test; p = 0.036, Figure 3C).
This effect is also observed when comparing the shift of ODI
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FIGURE 2 | PSA-NCAM expression in the Visual Cortex. (A) Confocal single plane showing the expression of PSA-NCAM in the primary visual cortex of control
mice. (B) Confocal single planes showing the expression of PSA-NCAM under different experimental conditions. Asterisks indicate the presence of PSA-NCAM
positive interneurons in the animals injected with vehicle, while they are absent in the animals injected intracerebrally with endoN. (C) Graphs showing the expression
of PSA-NCAM in our experimental conditions. EndoN removes effectively PSA-NCAM (2-way ANOVA), while in animals injected intracerebrally with vehicle,
Fluoxetine increases the expression of PSA-NCAM (Fisher’s LSD) Mean ± SEM (water-vehicle = 30.92 ± 5.8, water-endoN = 7.5 ± 1.7,
Fluoxetine-vehicle = 48.75 ± 8.1, Fluoxetine-endoN = 15.88 ± 0.95) n = 28 and ∗p < 0.05. Scale bar = 400 µm in (A) and 43 µm in (B).
with a 2-way ANOVA (factors: Fluoxetine and EndoN). We
indeed found a significant effect of Fluoxetine (F(1,27) = 5.102
and p = 0.032), no effect of endoN (F(1,27) = 0.332 and
p = 0.063), and no Fluoxetine-endoN interaction (F(1,27) = 0.089
and p = 0.76). These results suggest that depletion of PSA-NCAM
influenced neither the basal properties nor the fluoxetine-
induced plasticity of the ocular dominance in the mouse visual
cortex.
Both Fluoxetine and EndoN Alter the Basal
Activity of Parvalbumin Interneurons
Parvalbumin (PV) expressing interneurons are considered
key regulators of the critical period plasticity and their
axon terminals are modulated by PSA-NCAM expression
(Di Cristo et al., 2007; Castillo-Gómez et al., 2011). We
hypothesize that PSA-NCAMmodulation on the axon terminals
might affect the synaptic activity of PV interneurons. We
therefore analyzed the effects of chronic Fluoxetine treatment
and intracerebral injection of endoN on the expression
of the basal activity marker FosB (Nestler et al., 2001;
Robison and Nestler, 2011) in PV interneurons in the
primary visual cortex (Figures 4A,B). Fluoxetine treatment
produced a significant increase of FosB expression in PV
positive interneurons in animals injected with vehicle (Fisher’s
LSD; p = 0.020; Figure 4C). In addition, endoN injection
also increased FosB intensity in PV positive interneurons
compared to control animals (Fisher’s LSD; p = 0.0146;
Figure 4C). However, it is interesting to note that the
combination of chronic Fluoxetine and the removal of PSA
returned the expression of FosB to the basal control levels,
indicating an interaction (2-way ANOVA; F(1,31) = 11.36 and
p = 0.0020).
Finally, we analyzed more in detail the expression of PV.
By measuring the fluorescence intensity of PV, we found a trend
in the interaction between both factors: endoN and Fluoxetine
(2-way ANOVA; F(1,31) = 3.908 and p = 0.0570; Figure 4D).
In the multiple comparisons test, we found that in animals
injected intracerebrally with vehicle, Fluoxetine treatment
increased the fluorescence intensity of PV interneurons (Fisher’s
LSD; p = 0.0362). However, the total number of neurons in
the visual cortex was unaffected (2-way ANOVA; Fluoxetine:
F(1,31) = 0.2996 and p = 0.5881; endoN F(1,31) = 0.7434 and
p = 0.3952; Figure 4E).
DISCUSSION
In the present study, we have used ocular dominance
plasticity in the mouse visual cortex as a model to
investigate whether removal of PSA might influence the
Fluoxetine-induced reactivation of critical period-like
plasticity in the adult brain. We show that injection of the
enzyme endoN produces a clear removal of PSA that after
2 weeks extends to the visual cortex and most parts of
the telencephalon, indicating that the enzymatic treatment
reliably disrupts the PSA side chains of NCAM in adult
brain.
As previously reported in rats (Maya-Vetencourt et al., 2008),
we found that chronic Fluoxetine treatment reopens a period
of plasticity in the adult mouse visual cortex that resembles the
original critical period of postnatal development. Specifically,
chronic Fluoxetine treatment has also been demonstrated to
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FIGURE 3 | In vivo imaging of intrinsic signals. (A) Color-coded phase maps and gray-coded amplitude maps of activity evoked by the visual stimulus in a
representative animal from each group. Amplitude maps are displayed with a threshold at 70% of their maximal value, and the same masking was then applied to
amplitude maps. Histograms represent the ocular dominance index (ODI) value (by comparing the magnitude in response between the ipsilateral and contralateral
eye stimulation) before monocular deprivation (MD; upper part of each histogram) and after MD (lower part of each histogram). The arrows indicate significant shifts
in the ocular dominance. (B) Graph showing the frequency distribution of successful trials in the forepaw-reflex behavioral test. (C) Graph showing the mean ± SEM
of the shift in the ODI values (before and after MD; paired t-test; ∗p < 0.05). # Indicates that Fluoxetine as a factor produces a shift in the ODI compared to
water-drinking groups (2-way ANOVA; Mean ± SEM: water-vehicle = −0.0075 ± 0.093, water-endoN = −0.03125 ± 0.081, Fluoxetine-vehicle = 0.2117 ± 0.109,
Fluoxetine-endoN = 0.1367 ± 0.063 #p < 0.05; for more details, see “Results” Section).
produce an increase in PSA-NCAM expression and other
molecules involved in inhibitory neurotransmission (Varea et al.,
2007; Karpova et al., 2011; Ohira et al., 2013; Guirado et al.,
2014a). On the other hand, removal of PSA by intracerebral
infusion of endoN in the basolateral amygdala has been shown
to enhance extinction of fear memories (Markram et al., 2007).
At the cellular level, removal of PSA produces specific structural
plasticity changes in different subpopulations of interneurons
(Saarelainen et al., 2003; Varea et al., 2007; Guirado et al., 2014b).
Regarding visual plasticity, the decline of PSA-NCAM
expression after early development has been linked to the
earlier onset of critical period plasticity through an enhanced
perisomatic innervation by PV interneurons in the visual cortex
(Di Cristo et al., 2007). We hypothesized that the increased
PSA-NCAM expression produced by Fluoxetine, resembling that
high PSA-NCAM expression during development, might be
necessary for the structural remodeling underlying the shifts in
the ocular dominance. However, we have found that depletion of
PSA by the injection of endoN influenced neither the basal ocular
dominance conditions, nor the reactivation of juvenile-like
plasticity induced by Fluoxetine. Therefore, our results suggest
that PSA-NCAM is not required for the plasticity triggered by
Fluoxetine in the visual cortex.
The opening and closure of critical periods in the visual
cortex has been suggested to be dependent on the remodeling of
inhibitory circuits (Yazaki-Sugiyama et al., 2009; Harauzov et al.,
2010), and therefore the disruption the excitatory/inhibitory
balance (Hensch, 2005). Specifically, modulation of PV
interneurons activity has been suggested to play a role in
triggering critical period plasticity (Hensch, 2005; Kuhlman
et al., 2013).
Therefore we decided to study the expression of FosB as
a marker of basal long-term activity (Nestler et al., 2001;
Robison and Nestler, 2011; Nestler, 2015) in PV interneurons.
While we have found that Fluoxetine increases the expression
of PV in control animals, we also show that both chronic
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FIGURE 4 | Expression of FosB in Parvalbumin interneurons. (A) Confocal single plane showing the expression of PV and FosB in the primary visual cortex of
control mice. (B) Confocal single planes showing the expression of FosB in PV interneurons under different experimental conditions. Graphs showing the averages
± SEM of the intensity of fluorescence of (C) FosB in PV interneurons (water-vehicle = 52.38 ± 6.22, water-endoN = 76.58 ± 7.28, Fluoxetine-vehicle = 69.75 ±
7.20, Fluoxetine-endoN = 54.69 ± 4.7) and of (D) PV (water-vehicle = 7.93 ± 1.60, water-endoN = 16.25 ± 3.54, Fluoxetine-vehicle = 17.40 ± 2.93,
Fluoxetine-endoN = 13.85 ± 2.99; 2-way ANOVA with Fisher’s LSD multiple comparison test; ∗p < 0.05; # indicates that this group was not different from the control
group but different from the other two groups; for more details, see “Results” section). (E) Graph showing the density of interneurons expressing PV per 0.1 µm in
the primary visual cortex (water-vehicle = 9.86 ± 1.25, water-endoN = 11.50 ± 0.86, Fluoxetine-vehicle = 11.20 ± 0.86, Fluoxetine-endoN = 11.20 ± 0.83). Scale
bar = 400 µm in (A) and 25 µm in (B).
Fluoxetine treatment and PSA removal, independently produce
an increase in the expression of FosB in PV interneurons.
This is in line with a very recent study that showed an
increased FosB expression throughout the brain after Fluoxetine
treatment (Vialou et al., 2015). It is also in agreement with a
previous study that indicated an increase in the density of PV
and PV/synaptophysin expressing puncta on the perisomatic
region of pyramidal neurons after PSA removal (Castillo-
Gómez et al., 2011), what suggests an increased activity of
PV interneurons. In fact, PSA removal has previously been
suggested to lead to increased activity via BDNF (Burgess and
Aubert, 2006). However, it is interesting to note the negative
interaction between both factors as well, suggesting they act
through different mechanisms on PV interneurons. Further
experiments including control animals in which no monocular
deprivation is carried out, might help to understand this negative
interaction.
Since we observe an increase in the FosB expression in
PV interneurons in animals only injected with endoN, these
results indicate that the average changes of activity of PV
interneurons are not sufficient to trigger adult brain plasticity.
As it has been suggested previously, brain plasticity might
depend on the activity of few selected PV hub interneurons
(Bonifazi et al., 2009; Buzsáki, 2010; Royer et al., 2012;
Cossart, 2014). Therefore, it might be that our study masks
the specific changes in the activity of those few selected hub
PV interneurons. Nevertheless, further studies will be necessary
to understand the mechanisms through which antidepressants,
such as Fluoxetine, trigger critical period plasticity in the adult
brain.
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